Board Meeting14 Aug 2026, 08:30 pm
Aarey Drugs Board Approves Q1 FY27 Unaudited Financial Results
AI Summary
Aarey Drugs & Pharmaceuticals Ltd announced the outcome of its board meeting held on August 14, 2026. The board considered and approved the Unaudited Financial Results for the first quarter ended June 30, 2026, on a standalone basis. The approval also included the Limited Review Report and MD/CFO certification. Additionally, the board reviewed the Statement of Deviation or Variation in Utilization of Funds Raised through Convertible Warrants (Preferential Issue). The trading window will reopen 48 hours after the announcement of these results.
Key Highlights
- Board meeting held on August 14, 2026.
- Unaudited standalone financial results for Q1 FY27 approved.
- Limited Review Report and MD/CFO certification approved.
- Statement of Deviation or Variation in fund utilization reviewed.
- Trading window to reopen post-announcement.
Price Impact
More from AAREYDRUGS